To continue reading this content, please enable JavaScript in your browser settings and refresh this page. For American men, prostate cancer is the most common cancer ...

What key experiences or clinical gaps motivated your focus on advancing prostate cancer diagnostics, particularly MRI-led ...

February is National Cancer Prevention Month and to help people keep life flowing smoothly, the Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), is ...

Wood, 60, has now started chemotherapy to fight the cancer, which is the commonest form of the disease diagnosed in men, with ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about understanding Gleason Score and prostate cancer risk. As part of its Speaking ...

An article about the importance of PSA testing for early detection and treatment of prostate cancer ...

PSA and Ki-67 tumour markers may identify high-risk metastatic castration-sensitive prostate cancer and inform treatment ...

The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a substantial rise in medication treatments, such as chemotherapy, immunotherapy, ...

In cases of clinical equipoise, the highest MMAI score quartile could guide selective treatment intensification among patients with high-risk nonmetastatic prostate cancer. An artificial ...

Illuccix's label expansion aids in selecting patients for RLT in the pre-taxane setting, enhancing personalized treatment decisions for prostate cancer. The FDA's expanded approval of Pluvicto allows ...